Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Chase Pharmaceuticals Corp.
DescriptionCombination of Aricept donepezil, a reversible acetylcholinesterase (AChE) inhibitor, and solifenacin, a peripherally acting cholinergic blocker
Molecular Target Acetylcholinesterase (AChE)
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD); Treat Alzheimer's disease (AD) type dementia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today